The Clinical Proteomic Tumor Analysis Consortium (CPTAC) has produced large proteomics data sets from the mass spectrometric interrogation of tumor samples previously analyzed by The Cancer Genome ...

Like any other immunotherapy, response to ICB is contingent on immune cell recognition of tumor cells. To evade immune recognition, cancer cells can develop mechanisms to effectively disguise ...

Proliferating cell nuclear antigen (PCNA) is a central regulator of numerous cellular processes impacting DNA metabolism and genetic integrity, including DNA damage, cell cycle progression, and ...